The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

ATM

—ATM Serine/Threonine Kinase

Chromosome: 11

Location: 11:108222788-108369102

OMIM: 607585

Ensembl: ENSG00000149311

Official·OMIM:607585 Official·ENSG00000149311

Encodes DNA damage response kinase. Mutations cause ataxia-telangiectasia.

Treatment Roadmap — ATM

Preclinical

Phase 1

16 trial

Phase 2

22 trial

Phase 3

4 trial

Approved

Clinical trials have approximately 10% success rate. This roadmap shows the current status, not guaranteed outcomes.

Associated Diseases

Ataxia-Telangiectasia

Autosomal RecessivePrevalence: 1/100000oncologic

Official·OMIM:208900 Official·ORPHA100

Summary

Clinical Trial

Approved Therapy

Registered Variant